Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 21357 | 44.87 |
09:34 ET | 788 | 44.985 |
09:36 ET | 300 | 44.995 |
09:38 ET | 489 | 44.95 |
09:41 ET | 3160 | 45.1021 |
09:43 ET | 2142 | 45.08 |
09:45 ET | 1288 | 45 |
09:48 ET | 942 | 44.9 |
09:50 ET | 200 | 44.945 |
09:52 ET | 2186 | 45 |
09:54 ET | 1203 | 44.845 |
09:56 ET | 577 | 44.905 |
09:57 ET | 1158 | 44.86 |
09:59 ET | 1601 | 44.975 |
10:01 ET | 1758 | 44.99 |
10:03 ET | 900 | 44.96 |
10:06 ET | 1300 | 44.9925 |
10:08 ET | 2070 | 44.98 |
10:10 ET | 7635 | 44.915 |
10:12 ET | 2360 | 44.985 |
10:14 ET | 3854 | 45.075 |
10:15 ET | 1290 | 45.01 |
10:17 ET | 1547 | 45.04 |
10:19 ET | 6189 | 45.075 |
10:21 ET | 3400 | 45.18 |
10:24 ET | 2033 | 45.175 |
10:26 ET | 2166 | 45.2 |
10:28 ET | 5809 | 45.145 |
10:30 ET | 3777 | 44.91 |
10:32 ET | 864 | 44.93 |
10:33 ET | 2043 | 44.78 |
10:35 ET | 1391 | 44.76 |
10:37 ET | 5360 | 44.73 |
10:39 ET | 3923 | 44.7141 |
10:42 ET | 7831 | 44.69 |
10:44 ET | 1117 | 44.71 |
10:46 ET | 8252 | 44.59 |
10:48 ET | 4850 | 44.6 |
10:50 ET | 1735 | 44.6577 |
10:51 ET | 1751 | 44.61 |
10:53 ET | 6227 | 44.57 |
10:55 ET | 6831 | 44.505 |
10:57 ET | 2350 | 44.505 |
11:00 ET | 9844 | 44.38 |
11:02 ET | 3000 | 44.44 |
11:04 ET | 3688 | 44.425 |
11:06 ET | 2500 | 44.495 |
11:08 ET | 1083 | 44.5 |
11:09 ET | 600 | 44.505 |
11:11 ET | 1009 | 44.52 |
11:13 ET | 3663 | 44.625 |
11:15 ET | 3918 | 44.63 |
11:18 ET | 6163 | 44.665 |
11:20 ET | 1500 | 44.705 |
11:22 ET | 3494 | 44.67 |
11:24 ET | 6608 | 44.615 |
11:26 ET | 2667 | 44.59 |
11:27 ET | 4079 | 44.7 |
11:29 ET | 500 | 44.695 |
11:31 ET | 2255 | 44.8 |
11:33 ET | 650 | 44.77 |
11:36 ET | 2126 | 44.71 |
11:38 ET | 772 | 44.71 |
11:40 ET | 1927 | 44.749 |
11:42 ET | 1332 | 44.745 |
11:44 ET | 1016 | 44.74 |
11:45 ET | 2403 | 44.7 |
11:47 ET | 3127 | 44.7 |
11:49 ET | 500 | 44.71 |
11:51 ET | 3684 | 44.76 |
11:54 ET | 2713 | 44.8 |
11:56 ET | 500 | 44.8 |
11:58 ET | 2221 | 44.81 |
12:00 ET | 740 | 44.8 |
12:02 ET | 4301 | 44.77 |
12:03 ET | 2225 | 44.775 |
12:05 ET | 1910 | 44.89 |
12:07 ET | 3256 | 44.88 |
12:09 ET | 600 | 44.88 |
12:12 ET | 2156 | 44.865 |
12:14 ET | 3027 | 44.89 |
12:16 ET | 5511 | 44.9 |
12:18 ET | 4811 | 44.835 |
12:20 ET | 5763 | 44.875 |
12:21 ET | 3776 | 44.89 |
12:23 ET | 4916 | 44.89 |
12:25 ET | 5906 | 44.89 |
12:27 ET | 1220 | 44.88 |
12:30 ET | 15136 | 45.035 |
12:32 ET | 4417 | 45.3 |
12:34 ET | 4383 | 45.245 |
12:36 ET | 9646 | 45.31 |
12:38 ET | 3452 | 45.29 |
12:39 ET | 3615 | 45.27 |
12:41 ET | 2184 | 45.28 |
12:43 ET | 2491 | 45.28 |
12:45 ET | 3709 | 45.29 |
12:48 ET | 10999 | 45.35 |
12:50 ET | 4251 | 45.615 |
12:52 ET | 15445 | 45.65 |
12:54 ET | 9628 | 45.59 |
12:56 ET | 11068 | 45.71 |
12:57 ET | 32317 | 45.73 |
12:59 ET | 27699 | 45.6 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.6B | -17.1x | --- |
Halozyme Therapeutics Inc | 6.5B | 21.5x | --- |
Tempus AI Inc | 5.9B | -19.3x | --- |
Intra-Cellular Therapies Inc | 7.2B | -59.9x | --- |
Blueprint Medicines Corp | 6.9B | -22.6x | --- |
ACADIA Pharmaceuticals Inc | 2.6B | -1,211.3x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.6B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -17.1x |
Price/Sales (TTM) | 8.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.